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Abstract
Background—Alcohol is frequently co-abused with smoking. In humans, nicotine use can 
increase alcohol craving and consumption. The objectives of the current study were to assess the 
acute effects of nicotine on alcohol seeking and relapse at two different time points.
Method—Adult female alcohol-preferring (P) rats were trained in 2-lever operant chambers to 
self-administer 15% EtOH (v/v) and water on a concurrent fixed-ratio 5 – fixed-ratio 1 (FR5-FR1) 
schedule of reinforcement in daily 1-hr sessions. Following 10 weeks of daily 1-hr sessions, rats 
underwent 7 extinction sessions, followed by 2 weeks in their home cages. Rats were then 
returned to the operant chambers without EtOH or water being present for 4 sessions (Pavlovian 
Spontaneous Recovery [PSR]). Rats were then given a week in their home cage before being 
returned to the operant chambers with access to EtOH and water (relapse). Nicotine (0, 0.1, 0.3, or 
1.0 mg/kg) was injected s.c. immediately or 4-hr prior to PSR or relapse testing.
Results—Injections of nicotine immediately prior to testing reduced (5–10 responses PSR; 50–
60 responses relapse), whereas injections of nicotine 4-hr prior to testing increased (up to 150 
responses for PSR; up to 400 responses for relapse with 1.0 mg/kg dose) responses on the EtOH 
lever during PSR and relapse tests.
Discussion—The results of this study demonstrate that acute effects of nicotine on EtOH-
seeking and relapse behaviors may be time-dependent, with the immediate effects being a result of 
nicotine possibly acting as a substitute for EtOH whereas, with a delay of 4-hr, priming effects of 
nicotine alterations in nicotinic receptors, and/or the effects of nicotine’s metabolites (i.e., 
cotinine, nornicotine) may enhance the expression of EtOH-seeking and relapse behaviors.
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Nicotine is commonly co-abused with alcohol. Epidemiological and clinical studies 
estimated that 50–80% of alcohol-dependent individuals are regular smokers (Hurt et al., 
1994; Pomerleau et al., 1997; Romberger and Grant, 2004). Alcohol dependent individuals 
also have higher rates of nicotine dependence (Hughes, 1996; Room, 2004) and twin studies 
have shown that there may be common genetic mechanisms between alcohol dependence 
and nicotine dependence (Nurnberger et al., 2004; True et al., 1999; Volk et al., 2007). 
Alcohol intake is also significantly higher in smokers compared to only alcohol users (York 
and Hirsch, 1995).
Human and animals studies have demonstrated that the effects of nicotine on alcohol intake 
are complex. For example, two recent double-blind clinical studies demonstrated that 
transdermal nicotine or nicotine delivered by tobacco smoke can increase alcohol 
consumption in men (Acheson et al., 2006 and Barrett et al., 2006). In contrast, transdermal 
nicotine has been shown to decrease alcohol intake in women (Acheson et al., 2006) and 
delay alcohol drinking in heavy drinkers (McKee et al., 2008). Pre-clinical findings have 
provided further evidence that nicotine can increase ethanol (EtOH)-intake (Blomqvist et al., 
1996; Clark et al., 2001; Ericson et al., 2000; Lallemand et al., 2007; Le et al., 2003; 
Olausson et al., 2001; Potthoff et al., 1983; Smith et al., 1999), as wells as decrease it (Dyr 
et al., 1999; Nadal et al., 1998; Sharpe and Samson, 2002) in rodents. It has been suggested 
that the different effects observed after nicotine administration may be time-dependent due 
to the length of nicotine exposure (i. e., acute vs. repeated) or to the length of EtOH access 
(30-min vs. 60-min) (see Le, 2002).
Previous studies primarily focused on examining the effects of nicotine on EtOH intake. 
However, the concurrent use of alcohol with nicotine is also thought to increase the risk of 
alcohol-seeking and relapse further than alcohol use alone (Taylor et al., 2000). Given that 
relapse is a major problem in the treatment of alcohol addiction, some attention has been 
focused on how nicotine may affect EtOH-seeking and relapse drinking (Le et al., 2003; 
Lopez-Moreno et al., 2004).
Le et al. (2003) demonstrated that nicotine can reinstate EtOH-seeking behavior in Long-
Evans rats under operant conditions, whereas Lopez-Moreno et al. (2004) showed that 
nicotine can dose-dependently increase operant EtOH intake during alcohol deprivation in 
Wistar rats. These studies provide some evidence that nicotine use may be involved in 
increasing EtOH-seeking and relapse drinking in non-selective rats. However, the effects of 
nicotine on EtOH-seeking and relapse drinking in selectively bred high alcohol consuming 
rats have not been studied.
The selectively bred alcohol-preferring (P) line of rat has been well characterized both 
behaviorally and neurobiologically (McBride and Li, 1998; Murphy et al., 2002) and 
satisfies criteria proposed as essential for an animal model of alcoholism (Cicero, 1979; 
Lester and Freed, 1973). Alcohol-naïve P rats readily self-administer more nicotine as well 
as express greater nicotine-seeking behavior than the alcohol non-preferring (NP) rats (Le et 
al., 2006). Nicotine also has greater reinforcing effects in P than NP rats (Le at al., 2006), 
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which supports the hypothesis that alcohol and nicotine addiction share some common 
genetic risk factors.
Research assessing EtOH-seeking behavior through the expression of Pavlovian 
Spontaneous Recovery (PSR) paradigm has been conducted in P rats (Rodd-Henricks et al., 
2002a, b). PSR is a unique phenomenon in that it is time dependent, and the behavior 
appears to be dependent on the re-exposure of the organism to cues in the behavioral 
environment previously associated with the reinforcer. The expression of a PSR is directly 
correlated to reward saliency (Robbins, 1990), contextual cues associated with first-learned 
signals, and the amount of first- and second-learned associations (Brooks, 2000). The PSR 
phenomenon has been asserted to be the result of an intrinsic shift away from the recent 
extinction (second-) learning to the initial reinforced learning responses, which reflects a 
motivation to obtain the previously administered reward (Bouton 2002, 2004; Rescorla 
2001). Therefore, the PSR model may represent a unique paradigm to study EtOH-seeking 
behaviors. P rats readily express a PSR for EtOH (Rodd-Henricks et al. 2002a, b; Rodd et al. 
2006) and this expression can be enhanced by exposure to EtOH odor cues or EtOH priming 
(Rodd-Henricks et al. 2002a, b). In addition, P rats express pronounced relapse drinking 
under 24-hr free choice and operant conditions (McKinzie et al 1998; Rodd-Henricks et al., 
2000; Rodd et al., 2003; Toalston et al., 2008).
The objective of the current study was to test the hypothesis that nicotine will increase 




Adult female P rats from the 55th – 56th generations weighing 250–325g at the start of the 
experiment were used. Previous research indicated that EtOH intake of female P rats was not 
affected by the estrus cycle (McKinzie et al., 1998). Rats were maintained on a 12-hr 
reversed light-dark cycle (lights off at 0900-hr). Food and water were available ad libitum 
throughout the experiment, except during operant testing. The animals used in these 
experiments were maintained in facilities fully accredited by the Association for the 
Assessment and Accreditation of Laboratory Animal Care (AAALAC). All research 
protocols were approved by the institutional animal care and use committee and are in 
accordance with the guidelines of the Institutional Care and Use Committee of the National 
Institute on Drug Abuse, National Institutes of Health, and the Guide for the Care and Use 
of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life 
Sciences, National Research Council 1996).
aOperant Apparatus
EtOH self-administration procedures were conducted in standard two-lever experimental 
chambers (Coulbourn Instruments, Whitehall, PA, USA) contained within ventilated, sound-
attenuated enclosures. Two operant levers, located on the same wall, were 15 cm above a 
grid floor and 13 cm apart. A trough was directly beneath each lever, from which a dipper 
Hauser et al. Page 3









cup could raise to present fluid. Upon a reinforced response on the respective lever, a small 
light cue was illuminated in the drinking trough and 4 seconds of dipper cup (0.1 ml) access 
was presented. A personal computer controlled all operant chamber functions while 
recording lever responses and dipper presentations.
Operant Training
Without prior training, naïve P rats were placed into the operant chamber. Operant sessions 
were 60-min in duration and occurred daily (including weekends) for 10 weeks (Rodd et al., 
2006). The EtOH concentration used for operant administration was 15% (vol/vol). During 
the initial 4 weeks of daily operant access, both solutions (water and EtOH) were reinforced 
on an FR-1 schedule. At the end of this time, the response requirement for EtOH was 
increased to an FR-3 schedule for 3 weeks, and then to FR-5 schedule for 3 weeks. After the 
P rats had established stable levels of responding on the FR5 schedule for EtOH and FR1 for 
water, they underwent 7 days of extinction training (60-min/day), with neither water nor 
EtOH available (Rodd et al,. 2006). With the exception of no fluid being presented, the 
delivery system operated exactly as the preceding EtOH self-administration sessions.
Pavlovian Spontaneous Recovery (PSR) testing
After extinction training, all rats were maintained in the home cages for 14 days. Following 
the abstinence period, rats received additional operant sessions under the extinction protocol 
conditions. Lever contingencies and dipper functioning were maintained, but EtOH and 
water were absent. Rats were given 4 consecutive PSR test sessions (Rodd-Henricks et al., 
2002a, b; Rodd et al., 2006). There are 4 consecutive PSR session because previous studies 
have shown that exposure to EtOH odor cues or EtOH priming (Rodd-Henricks et al., 
2002a, b) and some drugs (Dhaher et al., 2009) may enhance PSR responding for more than 
one session.
Relapse
Following the PSR phase of the experiment, all rats were maintained in the home cages for 7 
days. Rats were then transferred to the operant chambers with both 15% EtOH and water 
available for the 60-min sessions. The EtOH lever was maintained on a FR5 schedule and 
the water lever on a FR1 schedule (Rodd et al., 2006).
Nicotine Effects on EtOH-Seeking and Relapse Drinking
Nicotine HCl was purchased from Sigma (St. Louis, USA). Nicotine HCl was dissolved in 
saline. Following extinction training, adult female P rats (n = 55) rats were randomly 
assigned to groups that received injections of nicotine (0, 0.1, 0.3, or 1.0 mg/kg, free base) 
immediately or 4-hr prior to the first PSR test session only (n = 6–10/dose/time point). Pilot 
testing revealed that nicotine injected 30-min prior to testing suppressed operant behaviors 
similar to that observed in the immediate condition; therefore, this time point was removed 
from the study. To reduce the number of rats used in the experiment, the saline group 
consisted of 9 rats distributed at each time point (n = 4–5/time point).
These same rats were also used to test the effects of nicotine during relapse responding, 
using a counterbalanced design (i.e., rats that were administered 1.0 mg/kg nicotine 
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immediately prior to PSR test sessions were randomly assigned to separate groups that 
received one of the 4 doses of nicotine). For relapse testing, rats received 0, 0.1, 0.3, or 1.0 
mg/kg nicotine (n = 7–9/group/time point) immediately or 4-hr prior to the 1st relapse 
session only. Similarly, to reduce the number of rats used in the experiment, the saline group 
consisted of 9 rats distributed at each time point (n = 4–5/time point).
Statistical Analyses
Overall operant responding (60-min) data were analyzed with a mixed factorial ANOVA 
with a between subject factors of dose and time point and a repeated measure of ‘session’. 
For the PSR experiments, the baseline measure for the factor of ‘session’ was the average 
number of responses on the EtOH lever for the last 3 extinction sessions. For the relapse 
studies, the baseline measure for the factor of ‘session’ was the average number of responses 
on the EtOH lever for the 3 sessions immediately prior to deprivation. Operant responding 
data were also analyzed in 10-min blocks, which required the additional repeated measure of 
time. Post-hoc Tukey’s b tests were performed to determine individual differences.
RESULTS
Nicotine administered immediately prior to PSR testing reduced operant responding on the 
EtOH lever (top panel, Fig. 1), whereas nicotine administered 4 hr prior to PSR testing 
increased responding on the EtOH lever (bottom panel, Fig. 1). There was a significant 
effect of ‘session’ (F4, 44 = 35.8; p < 0.001), ‘dose’ (F3, 47 = 4.5; p = 0.007), and ‘session’ by 
‘dose’ by ‘time of injection’ interaction (F12, 138 = 4.5; p < 0.001). Decomposing the 
interaction term by holding ‘time of injection’ constant revealed, for rats injected 
immediately prior to PSR testing, there was a significant ‘session’ by ‘dose’ interaction 
(F12, 63 = 2.7; p < 0.001). Individual One-way ANOVAs performed on each session 
indicated that only during the 1st PSR test session was there a significant ‘dose’ effect (F3, 22 
= 34.5; p < 0.001). Post-hoc comparisons indicated that all 3 nicotine groups responded less 
than the saline treated rats during the 1st PSR test session. Comparison with extinction 
baseline levels of responding indicated that the saline treated rats increased responding on 
the lever previously associated with the delivery of EtOH during the 1st PSR session, 
whereas rats treated with each dose of nicotine reduced responding (paired t-tests, p values < 
0.001).
For rats injected 4-hr prior to PSR testing, a significant ‘session’ by ‘dose’ interaction 
(F12, 72 = 2.9; p < 0.001) was revealed (Fig. 1). The ‘dose’ groups differed only during the 
1st PSR test session (F3,25 = 25.6; p < 0.001), and post-hoc comparisons indicated that rats 
administered 1.0 mg/kg nicotine 4-hr prior to testing increased EtOH-lever responses 
compared to all other groups. Comparison with extinction baseline levels of responding 
indicated that all groups increased responding on the lever previously associated with the 
delivery of EtOH during the 1st PSR session (paired t-tests, p values < 0.008).
Examining the time course effects of nicotine (in 10-minute blocks) within the first PSR 
session (Fig. 2), indicated a significant ‘time of injection’ x ‘dose’ x ‘session time’ block 
interaction (F15, 135 = 2.8; p < 0.001). Reducing the interaction term by holding ‘dose’ 
constant, indicated a significant ‘time of injection’ x ‘session time’ interaction (p values < 
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0.004) in rats administered 0.1, 0.3 or 1.0 mg/kg nicotine. Analysis performed on the saline 
group revealed no effect of ‘time of injection’ x ‘session time’ interaction (p values < 0.68) 
in rats administered 0.1, 0.3 or 1.0 mg/kg nicotine. Rats treated with nicotine immediately 
prior to testing (open circles, all panels Fig. 2) displayed a reduction in responding 
compared to saline during 0–20-min of PSR testing and this reduced responding continued 
throughout the 60-min session. The rats injected 4-hr prior to the 1st PSR session showed 
that saline, 0.1, 0.3, and 1.0 mg/kg all showed significantly more responding than the group 
given nicotine immediately prior to the session during the beginning of the 60-min sessions. 
Further, the rats administered 0.3 or 1.0 mg/kg nicotine 4-hr prior to PSR testing also 
displayed an increase in responding during the end of the 60-min test session compared to 
saline treated rats (middle and bottom panel, Fig. 2). The time pattern of high responding at 
the beginning and at end of the session for the 0.3 and 1.0 mg/kg groups resulted in the 
overall enhanced PSR responding for both groups compared to saline and 0.1 mg/kg.
Responding on the lever previously associated with water was significantly lower (paired t-
tests, p =0.033) in the 0.3 mg/kg nicotine group compared to extinction baseline values (top 
panel, Fig. 3). There were no a significant differences in water responding for the 1st PSR 
session for the saline, 0.1 mg/kg or 1.0 mg/kg nicotine groups compared to extinction 
baseline values (paired t-tests, p ≥ 0.060). In addition, there were no significant group 
differences (p values > 0.05) on water lever responses between saline, 0.1 mg/kg, 0.3 mg/kg, 
and 1.0 mg/kg nicotine during the 1st PSR session (top panel, Fig. 3).
Responding on the lever previously associated with water was significantly higher in the 
saline (paired t-tests, p =0.015) and 0.1 mg/kg nicotine (paired t-tests, p =0.021) groups 
compared to extinction baseline values (bottom panel, Fig. 3) for the 4-hr delay. There were 
no significant differences in responses on the water lever for the 0.3 mg/kg or 1.0 mg/kg 
nicotine groups compared to extinction baseline values during the 1st PSR session (paired t-
tests, p ≥ 0.456). When the 4-hr delay groups were compared to each other the analysis 
revealed that responding on the water lever for saline and 0.1 mg/kg nicotine groups were 
significantly higher (p values < 0.05) than 0.3 mg/kg and 1.0 mg/kg nicotine during the 
initial PSR session (bottom panel, Fig. 3).
A similar time-dependent pattern to that found during PSR testing was also observed when 
nicotine was administered immediately or 4-hr prior to EtOH relapse testing (top panel, Fig. 
4). Decomposing the interaction term by holding ‘time of injection’ constant indicated that 
in rats injected immediately prior to EtOH reinstatement (top panel, Fig. 4), there was a 
significant ‘session’ x ‘dose’ interaction (F18,57 = 5.3; p = 0.002). Individual ANOVAs 
indicated there was a significant ‘dose’ effect during the 1st relapse session (F3, 22 = 7.6; p < 
0.001). Post-hoc comparisons indicated that responding by the saline group was significantly 
higher than all nicotine groups and baseline values. There was no significant effect of group 
during the 2nd relapse session (p = 0.063) or subsequent sessions. In addition, responses on 
the EtOH lever for all nicotine groups were lower than baseline values during the 1st 
session; during the 2nd session only the 0.1 and 1.0 mg/kg nicotine doses reduced responses 
below baseline.
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For rats injected with nicotine 4-hr prior to EtOH relapse testing (bottom panel, Fig. 4), 
there was a significant ‘session’ effect (F6, 20 = 10.8; p < 0.001). An ANOVA performed on 
the 1st relapse session (p = 0.033) indicated that rats given 0.3 or 1.0 mg/kg nicotine 4-hr 
prior to the relapse session responded more on the EtOH lever than the saline group (Fig. 4). 
Comparison with baseline indicated that all rats in the 4-hr group responded more during the 
1st relapse session than during baseline (p values ≤ 0.03).
The average baseline for EtOH intake prior to relapse testing for both immediate and 4-hr 
groups was approximately 1.5 g/kg in a 60-min sessions. The immediate and 4-hr delay 
saline groups during EtOH relapse increased EtOH intakes to around 2 g/kg. The immediate 
effects of nicotine reduced EtOH intake to 0.4–0.6 g/kg. The 4-hr delay effects of nicotine 
increased EtOH intakes as high 3 g/kg.
Examining the time course effects (in 10-min bins) of administration of nicotine on EtOH 
relapse during the 1st relapse session (Fig. 5) indicated that the EtOH lever responding 
temporal profile was influenced by both nicotine dose and ‘time of injection’. An analysis of 
the EtOH relapse responding separated into 10-min blocks indicated a significant ‘time of 
injection’ x ‘session time’ interaction (F5, 43 = 10.4; p < 0.001). In general, nicotine 
administered immediately prior to the 1st relapse session reduced EtOH self-administration 
throughout the 60-min test session compared to saline values. In general, administration of 
nicotine 4-hr prior to the relapse session increased responding during the beginning and the 
end of the 1st relapse session. For rats administered 0.1 mg/kg nicotine 4-hr prior to relapse 
(top panel, Fig. 5), responding was greater than saline during the 1st 10-min block. For rats 
administered 0.3 mg/kg nicotine 4-hr prior to relapse (middle panel, Fig-5), responding was 
greater than saline during the 3rd and 6th 10-min blocks. For rats administered 1.0 mg/kg 
nicotine 4-hr prior to the 1st relapse session (bottom panel, Fig. 5), responding was greater 
than saline during the 1st, 2nd, and 6th 10-min blocks.
There were no significant differences in water relapse responding when the rats were 
administered saline or nicotine immediately prior to the 1st relapse session compared to 
baseline values (paired t-tests, p values ≥ 0.085), nor were there water responding 
differences when the groups were compared to each other (p values = 0.112, top panel, Fig. 
6). However, rats administered saline or 0.1 mg/kg of nicotine 4-hr prior to the 1st relapse 
session responded significantly (paired t-tests, p = 0.015) more on the water lever compared 
to baseline values (bottom panel, Fig. 6). There were no significant differences in water 
responding when rats were administered 0.3 or 1.0 mg/kg nicotine 4-hr prior to the 1st 
relapse session (paired t-tests, p values > 0.05). In addition, there were no significant group 
differences on water responding between rats administered saline or 0.1, 0.3 or 1.0 mg/kg 
nicotine 4-hr prior to the 1st relapse session (bottom panel, Fig. 6).
DISCUSSION
The major findings of this study demonstrated that the enhanced expression of EtOH-
seeking and EtOH-relapse by acute doses of nicotine is time-dependent. In the present study, 
the PSR and relapse paradigms were used to access EtOH-seeking and EtOH- relapse 
behaviors, respectively.
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The doses of nicotine are comparable to the nicotine doses used in previous experiments (Le 
et al., 2003; Lopez-Moreno et al., 2004). The 4-hr delay between nicotine administration and 
EtOH access showed that nicotine dose–dependently increased both PSR and EtOH-relapse 
(lower panels, Figs. 1 and 4), whereas the saline and 0.1 mg/kg of nicotine groups showed 
increased responses on the water lever for both PSR and water relapse (lower panels, Figs. 3 
and 6). The mid- (0.3 mg/kg) and high- (1.0 mg/kg) dose of nicotine did not have any effect 
on water lever responding for PSR or relapse (lower panels, Figs. 3 and 6). These results 
reveal that the 4-hr delay of nicotine did not lead to general enhancement of locomotor 
activity because water lever responses for the mid- and high-dose nicotine groups did not 
differ from baseline water lever responses. In addition, the saline group’s water lever 
responses were very similar to responses observed for the low-dose nicotine groups. The 
enhancement of EtOH-seeking and EtOH-relapse like self-administration that we observed 
is also not likely due to nicotine withdrawal because it was single administration of nicotine 
and the animals did not exhibit any of the somatic symptoms of nicotine withdrawal (i.e., 
abdominal constrictions, facial fasciculation, increased eye blinks, and ptosis).
Our results are in line with Le et al. (2003) findings that demonstrated repeated nicotine 
administration can increase EtOH-seeking behavior, as well as the findings of Lopez-
Moreno et al. (2004) that showed repeated nicotine administrations can enhance EtOH-
relapse-like drinking for up to two weeks. The difference between our study and the 
previous studies is that a single administration of nicotine and 4-hr delay prior to the operant 
sessions increased EtOH-seeking and relapse responding in P rats. Interestingly, Katner et 
al. (1997) showed that EtOH intake in P rats starts to recovery 4-hr after acute nicotine 
administration. Taken together, these studies suggest that nicotine’s acute priming effects 
may lead to enhancement of EtOH-seeking and relapse long after the dissipation of nicotine.
The desensitization or inactivation of nicotinic acetylcholine receptors (nAChRs) may be 
involved in the delayed enhancement of PSR and EtOH relapse responding by nicotine. 
Nicotine can rapidly desensitize nAChR subtypes (i.e., α4β2) for prolonged periods of time 
(Mansvelder et al., 2002; Pidoplichko et al., 1997, 2004). It has been reported that a single 
exposure of nicotine can reduce nAChRs function for 24-hr and that these receptors remain 
desensitized even after repeated exposure to nicotine (Vann et al., 2006). There is also 
evidence that EtOH can enhance desensitization of nAChRs caused by nicotine (Nagata et 
al., 1996), as well as the behavioral desensitization induced by pretreatment with nicotine 
(de Fiebre and Collins, 1989). Therefore, it is possible that the enhancement of EtOH-
seeking and EtOH-relapse observed in the current study may be due to the desensitization of 
nAChRs caused by nicotine.
An alternative reason for the enhancement of EtOH-seeking and EtOH-relapse drinking for 
the 4-hr delay group may be due to active nicotine metabolites. Nicotine has several 
metabolites that have a longer half-life than nicotine itself. Cotinine is major metabolite of 
nicotine and its half-life ranges from 5 to ~ 7 hours in rat plasma (Kyerematen et al., 1988; 
Miller et al., 1977) and 5.6 hours in the brain (Ghosheh et al., 1999). Studies have shown 
that cotinine can stimulate nicotinic mechanisms to release noradrenaline (Vainio et al., 
1998) and DA (Dwonski et al., 1999b), inhibit the binding of cholinergic receptors 
(Anderson and Arneric, 1994; Riah et al., 1999; Sloan et al., 1984), and desensitize nicotinic 
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receptors (Dwoskin et al., 1999b). However, the cotinine concentrations necessary to 
increase extracellular DA have to be relatively high (Dwoskin et al., 1999b). Interestingly, 
not all of cotinine actions are mediated through cholinergic receptors. Riah et al. (2000) 
results provided the first molecular evidence that cotinine may have its own distinctive 
cotinine receptors. Cotinine has also been shown to reduce neuronal 5-HT turnover (Fuxe et 
al., 1979). Nicotine’s second largest metabolite nornicotine has a half-life of 2.8 hours in the 
brain (Ghosheh et al., 1999) to 3.3 hours in plasma (Kyerematen and Vesell, 1991). 
Nornicotine can also cause nicotinic receptor desensitization (Dwoskin et al., 1999a, 2001); 
it has reinforcing actions similar to nicotine (Bardo et al., 1999), and can act as a substitute 
for nicotine (Reichel et al., 2010). Although there is no current research on how nicotine’s 
metabolites may affect EtOH-seeking behavior or relapse like drinking, it is possible that 
one of nicotine’s metabolites may enhance EtOH-seeking behavior and EtOH- relapse like 
drinking after the 4-hr delay.
The present results showed that all doses of nicotine injected immediately prior to testing 
reduced both PSR and EtOH-relapse responding of P rats (top panels, Figs. 1 and 4), 
whereas only 0.3 mg/kg of nicotine injected immediately prior to PSR testing reduced 
responses on the lever previously associated with water (top panel, Fig. 3). The low (0.1 
mg/kg) and the high (1.0 mg/kg) immediate doses of nicotine did not have any effect on 
water lever responding in the PSR test. None of the immediate doses of nicotine had any 
effect on water relapse responding when compared to baseline or among groups (top panel, 
Fig. 6). Interestingly, all doses of nicotine, given immediately before the operant session, 
reduced responding on the EtOH lever to approximately the same level in the PSR test and 
during relapse (upper panel, Figs. 1 and 4). This reduction is not likely due to a general 
suppressant effect on general locomotor activity since a dose of 0.8 mg/kg has been reported 
to enhance locomotor activity of P rats (Gordon et al., 1993b), and there was no definitive 
reduction in responding on the water lever during the PSR test or during relapse by P rats 
treated with nicotine (top panel, Figs. 3 and 6). The lack of a dose-dependent effect on EtOH 
lever responding during the PSR test and relapse by nicotine, when given immediately prior 
to the session, may be a result of the P rat being more sensitive to the stimulating and EtOH 
discriminative effects of nicotine (Gordon et al., 1993a, b). Therefore, it is possible that the 
EtOH PSR and relapse responding by the P rats may be sensitive to the immediate effects of 
nicotine, such that the 0.1 mg/kg dose is producing a maximal effect, which may reflect the 
greater EtOH discriminative stimulus and locomotor stimulating effects of nicotine for the P 
compared to the NP rat (Gordon et al., 1993a, b).
The current findings for the non-delayed groups of nicotine are in line with previous studies 
that showed when nicotine was administered immediately-to-30-min prior to EtOH access, 
there was a reduction in EtOH intake (see Le, 2002). Administration of nicotine into the 
lateral ventricles 15-min before limited EtOH access dose-dependently decreased EtOH 
intake within the first 30-min without altering saccharin intake of P rats (Katner et al., 
1997). Local application of nicotine into the nucleus accumbens 10-min prior to EtOH 
access decreased EtOH operant self-administration in Long-Evans rats without altering 
sucrose self-administrations (Nadal et al., 1998). Peripheral administration of nicotine 
immediately prior to EtOH-access has also been shown to decrease EtOH consumption (Dyr 
et al., 1999). On the other hand, Gauvin et al. (1993) found a biphasic effect of acute 
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nicotine on EtOH consumption in Sprague-Dawley rats. Low-dose nicotine (0.1 mg/kg), 
administered 15-min before EtOH access, increased EtOH intake, whereas higher doses 
(0.18 and 0.32 mg/kg), which are similar concentrations used in more recent studies, 
reduced EtOH intake. For P rats, a biphasic effect of nicotine on EtOH-seeking or EtOH 
relapse like self-administration was not observed (top panels, Figs. 1 and 4). The low-dose 
produced similar reductions as the mid and high doses of nicotine, suggesting that P rats 
may be more sensitive to the effects of nicotine than non-selective rats (top panels, Figs. 1 
and 4).
One possible explanation for the reduction of EtOH-seeking and EtOH-relapse responding 
by P rats is that the initial effects of nicotine may be to substitute for EtOH. Interestingly, 
drug discrimination studies have shown that EtOH discriminative stimulus generalizes to 
nicotine in P rats compared to the NP rats (Gordon et al., 1993a; McMillan et al., 1999) and 
that P rats are more likely to substitute nicotine for EtOH (McMillan et al., 1999). Le at al. 
(2006) findings showed that EtOH-naïve P rats will self-administer more nicotine and 
express greater nicotine-seeking behavior than NP rats. Le et al. (2006) findings in P rats 
provided support for the hypothesis that nicotine and alcohol addiction may share a common 
genetic vulnerability and this shared common genetic vulnerability may also help explain 
why the initial effects of nicotine reduced EtOH-seeking and EtOH-relapse self-
administration drinking behavior in P rats.
The mechanisms underlying nicotine’s effect on EtOH-seeking or relapse behavior are not 
understood. However, activation of the mesolimbic dopamine (DA) system is thought to be 
involved in mediating compulsive drug seeking and drug taking behaviors. EtOH can 
enhance DA neurotransmission by increasing the firing rate of DA neurons (Brodie et al., 
1990; Gessa et al., 1985) and somatodendritic DA release in the VTA (Campbell et al., 
1996; Kohl et al., 1998), subsequently leading to an increase in extracellular levels of DA in 
the nucleus accumbens (Imperato and Di Chiara, 1986; Kohl et al., 1998; Yoshida et al., 
1993). Similar findings have shown that nicotine can also enhance DA neurotransmission by 
increasing the firing rate of DA neurons (Grenhoff et al., 1986) and somatodendritic DA 
release in the VTA (Rahman et al., 2003, 2004), subsequently leading to an increase in 
extracellular levels of DA in the nucleus accumbens (Ferrari et al., 2002; Imperato et al., 
1986b; Nisell et al., 1994; Tizabi et al., 2002).
Nicotine has a half-life that ranges from 55 to 64-min in plasma (Miller et al., 1977) and 30 
to 60-min in brain (Ghosheh et al., 1999; Rossi et al., 2005; Sastry et al., 1995). Nicotine 
brain concentration levels can reach their peak in less than 10-min (Rossi et al., 2005). A 
single administration of nicotine can stimulate DA neurotransmission for over an hour after 
nicotine administration (Di Chiara and Imperato, 1988; Imperato et al., 1986b; Pidoplichko 
et al., 2004; Schilstrom et al., 1998). This prolonged DA neurotransmission is due to α7 
nAChRs on the presynaptic glutamate terminals, which do not desensitize to nicotine, but 
continue to enhance glutamatergic excitation in the presence of nicotine (Pidoplichko et al., 
2004).
Some studies have shown that blocking nAChR can decrease EtOH-self administrations in 
animals (Blomqvist et al., 1996; Farook et al., 2009; Hendrickson et al., 2009; Kuzmin et al., 
Hauser et al. Page 10









2009; Le et al., 2000), alcohol drinking in humans (Chi and deWit, 2003), and block EtOH 
induced extracellular DA release (Blomqvist et al., 1993, 1997), thus providing evidence 
that some of EtOH reinforcing effects may be mediated via nAChRs. It is noteworthy to 
mention that the majority of pre-clinical studies, which observed nicotine increasing EtOH 
intake, administered nicotine repeatedly, or at a constant rate (Blomqvist et al., 1996; Clark 
et al., 2001; Ericson et al., 2000; Olausson et al., 2001; Pothoff et al., 1983; Smith et al. 
1999), whereas those that examine acute effects of nicotine on EtOH intake observed a 
reduction (Dyr et al., 1999; Gauvin et al., 1993; Katner et al., 1997; Nadal et al., 1998). 
Thus, it is possible that the initial DA stimulating effects of nicotine, when it is administered 
immediately prior to the tests, may be a viable substitute for EtOH under seeking and 
relapse conditions. However, taken into account that nicotine doses have significantly 
decreased after 4-hr suggests that enhancement of EtOH-seeking and EtOH-relapse 
responding are occurring long after the stimulatory effects of nicotine on DA release. 
Therefore, in the current study it seems unlikely that the enhancement of EtOH-seeking and 
EtOH-relapse responding by nicotine is due to increased DA release.
Another factor to take into consideration is that neuroadaptations can occur after chronic 
drinking and that repeated alcohol deprivations may produce further increases in the 
reinforcing effects and the sensitivity of EtOH within the mesolimbic DA system (Rodd et 
al., 2005a, b). Furthermore, it is thought that drugs of abuse can prime responding by 
activating the mesolimbic DA system, which has become sensitized with repeated drug use 
in a long lasting manner (Robinson and Berridge, 1993). Alcohol can also enhance the 
function of several subtypes of nAChRs (i.e., α4β2, α4β4, α2β2, and α2β4) (see Davis and 
de Fiebre, 2006; Cardoso et al. 1999; Narahashi et al., 1999, 2001), have little to no effect on 
other subtypes (i.e., α3β2 and α3β4) (see Davis and de Fiebre, 2006; Cardoso et al., 1999), 
or inhibit other nAChR subtypes (i.e., α7) (Cardoso et al. 1999; see Davis and de Fiebre, 
2006; de Fiebre and de Fiebre 2005; Narahashi et al., 1999, 2001; Yu et al. 1996). In the 
current study, PSR was examine after 21 days of EtOH deprivation and EtOH-relapse after 
32 days of EtOH deprivation, nicotine’s effects may be acting on a sensitized mesolimbic 
DA system with various nAChR alterations. Hence, further alterations of this system after 
chronic drinking and abstinence may also contribute to the effects of nicotine that were 
observed in these animals during PSR and EtOH relapse.
In order to obtain a better understanding of nicotine’s time-dependent effects on EtOH-
seeking and relapse behaviors, EtOH responding in 10-min bins was examined (Figs. 2 and 
5). Previous research demonstrated that only the 0.8 mg/kg dose of nicotine suppressed 
EtOH responding of non-selective Wistar rats in the first 20-min; however, EtOH 
responding started to increase after this time point, resulting in enhanced EtOH intake (Le et 
al., 2000). Le (2002) suggested that the suppression of EtOH intake observed in studies that 
administered nicotine acutely may be due to the length of EtOH access, suggesting that 
shorter durations (30-min) to EtOH access may mask nicotine’s effect on EtOH intake, 
because nicotine initially reduces EtOH intake in the first 20-min and increases EtOH intake 
towards the end of the 60-min session (Le et al., 2000; see Le, 2002). The current10-min bin 
data revealed that all nicotine doses suppressed the initial response of EtOH-seeking and 
relapse responding within the first 20-min in the non-delayed groups compared to the saline 
group (Fig. 2). However, unlike the Le et al. (2000) study, the suppression of these 
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behaviors in P rats continued throughout the entire 60-min session. Taken together, these 
results provide evidence that P rats are more sensitive to the effects of nicotine than non-
selective rats because the effects of nicotine did not rebound after the initial 20-min 
suppression. In addition, further examination of the time course for the 4-hr delayed group 
showed that the increase of EtOH-seeking and relapse generally occurred in the first 30-min 
and/or last 10-min of the 60-min sessions (Fig. 5). For example, the mid- (middle panels, 
Figs. 2 and 5) and high- (lower panels, Figs. 2 and 5) doses of nicotine for the 4-hr delayed 
group tended to increase EtOH-seeking and relapse at the beginning and towards the end of 
the 60-min sessions, whereas the saline group only increased EtOH-seeking at the beginning 
followed by reduction in responses from 30-min to the end of the session. This led to the 
overall enhancement of PSR and EtOH-relapse for 0.3 mg/kg and 1.0 mg/kg nicotine 4-hr 
delayed groups compared to saline and shows that priming effects of the higher doses of 
nicotine actively motivated the animals to obtain EtOH at beginning and end of the 60-min 
sessions even when EtOH was unavailable (PSR). The 0.1 mg/kg nicotine dose was similar 
to saline group and the enhancement of EtOH-seeking was only observed at the beginning of 
session regardless of time, whereas the enhancement of relapse drinking was observed at the 
beginning and towards the end for both saline and the 0.1 mg/kg nicotine groups. Taken 
together, these results suggest that time and dose of nicotine administration are important 
factors in the enhanced expression of EtOH-seeking and relapse in P rats.
In conclusion, these findings suggest that the effects of nicotine on EtOH-seeking and 
EtOH-relapse behaviors in P rats may depend on the temporal assessment of the behaviors 
post drug administration. Further alterations of neuronal systems after chronic drinking and 
abstinence may also contribute to nicotine’s effect on the enhancement of EtOH-seeking and 
EtOH-relapse responding observed in these animals.
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Mean (± S.E.M.) responses per session on the lever previously associated with the delivery 
of EtOH in P rats given saline (n = 4–5/time point) or 0.1, 0.3, or 1.0 mg/kg nicotine (n = 6–
10/dose/time point) subcutaneously immediately or 4-hr prior to the first PSR session. 
Upper Panel: asterisk (*) indicates that rats administered saline responded significantly (p < 
0.05) more on the EtOH lever during the first PSR session compared to extinction baseline 
levels, whereas rats administered 0.1, 0.3, or 1.0 mg/kg nicotine immediately prior to the 
first PSR session responded significantly less than extinction baseline. Pound (#) indicates 
that all doses of nicotine reduced EtOH responding during the first PSR session compared to 
the saline group (p<0.05). Lower Panel: asterisk (*) indicates that rats administered saline, 
0.1, 0.3, or 1.0 mg/kg nicotine 4-hr prior to the first session responded significantly (p < 
0.05) more on the EtOH lever during the first PSR session compared to extinction baseline 
levels. Pound symbol (#) indicates that 1.0 mg/kg nicotine increased EtOH responding 
during the first PSR session compared to all other groups (p < 0.05).
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Mean (± S.E.M.) responses per 10-min blocks on the lever previously associated with the 
delivery of EtOH in P rats given saline (n = 4–5/time point), or 0.1, 0.3, or 1.0 mg/kg 
nicotine (n = 6–10/dose/time point) immediately or 4-hr prior to only the first PSR session. 
Upper Panel: asterisk (*) indicates that rats administered 0.1 mg/kg nicotine immediately 
prior to the test session responded significantly (p < 0.05) less on the EtOH lever during 0–
20-min of PSR testing compared to saline. Middle Panel: asterisk (*) indicates that rats 
administered 0.3 mg/kg nicotine immediately prior to first the PSR session responded 
significantly (p < 0.05) less on the EtOH lever during 0–20-min of PSR testing compared to 
saline and rats administered 0.3 mg/kg nicotine 4-hr prior testing. Rats administered 0.3 
mg/kg nicotine 4-hr prior to PSR testing displayed an increase in EtOH lever responses 
during the 50–60 period. Lower Panel: asterisk (*) indicates that rats administered 1.0 
mg/kg nicotine immediately prior to test session responded significantly (p < 0.05) less on 
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the EtOH lever during 0–20-min of PSR testing compared to saline and rats administered 1.0 
mg/kg nicotine 4-hr prior testing. Rats administered 1.0 mg/kg nicotine 4-hr prior to PSR 
testing displayed an increase in EtOH responses during the 40–60 period.
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Mean (± S.E.M.) responses per session on the lever previously associated with the delivery 
of water in P rats given saline (n = 4–5/time point), or 0.1, 0.3, or 1.0 mg/kg nicotine (n = 6–
10/dose/time point) subcutaneously immediately or 4-hr prior to the first PSR session. 
Upper Panel: asterisk (*) indicates that rats administered 0.3 mg/kg nicotine responded 
significantly (p < 0.05) less on the water lever during the first PSR session compared to 
extinction baseline levels. There were no significant water responding differences when 
animals were administered saline or 0.1 or 1.0 mg/kg of nicotine immediately prior to the 
first PSR session. Lower Panel: asterisk (*) indicates that rats administered saline or 0.1 
mg/kg nicotine 4-hr prior to the first session responded significantly (p < 0.05) more on the 
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water lever during the first PSR session compared to extinction baseline levels. There were 
no significant water responding differences when animals were administered 0.3 or 1.0 
mg/kg nicotine 4-hr prior to the first PSR session.
Hauser et al. Page 22










Mean (± S.E.M.) responses per session on the EtOH lever by P rats given saline (n = 4–5/
time point), or 0.1, 0.3, or 1.0 mg/kg nicotine (n = 7–9/group/time point) immediately or 4-
hr prior to only the first relapse session. Upper Panel: asterisk (*) indicates that rats 
administered 0.1, 0.3, or 1.0 mg/kg nicotine immediately prior to the first relapse session 
responded significantly (p < 0.05) less than baseline, and rats given saline had higher 
responding than baseline. Pound symbol (#) indicates that all doses of nicotine reduced 
EtOH responding during the first relapse session compared to the saline group (p<0.05). 
Lower Panel: asterisk (*) indicates that rats administered saline or 0.1, 0.3, or 1.0 mg/kg 
nicotine 4-hr prior to the first relapse session responded significantly (p < 0.05) more on the 
EtOH lever compared to baseline levels. Pound symbol (#) indicates that 0.3 and 1.0 mg/kg 
nicotine increased EtOH responding significantly more than the saline group (p < 0.05).
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Mean (± S.E.M.) responses per 10-min blocks on the EtOH lever by P rats given saline (n = 
4–5/time point), or 0.1, 0.3, or 1.0 mg/kg nicotine (n = 7–9/group/time point) immediately or 
4-hr prior to the first relapse session. Upper Panel: asterisk (*) indicates that rats 
administered saline or 0.1 mg/kg 4-hr prior to test session responded significantly (p < 0.05) 
more on the EtOH lever during initial 0–20-min and final 10-min of relapse testing 
compared to rats injected with 0.1 mg/kg nicotine immediately prior to the test session. 
Middle Panel: asterisk (*) indicates that rats administered 0.3 mg/kg nicotine immediately 
responded significantly (p < 0.05) less on the EtOH lever during 0–20-min of relapse testing 
compared to saline, and rats administered 0.3 mg/kg nicotine 4-hr prior to relapse testing 
displayed an increase in EtOH responding during the 3rd and 6th 10-min block compared to 
saline. Lower Panel: asterisk (*) indicates that rats administered 1.0 mg/kg nicotine 
immediately responded significantly (p < 0.05) less on the EtOH lever during 0–20-min of 
relapse testing compared to saline, and rats administered 1.0 mg/kg nicotine 4-hr prior to 
relapse testing displayed an increase in EtOH lever responses during 1st, 2nd, and 6th 10-min 
block compared to saline.
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Mean (± S.E.M.) responses per session on the water lever by P rats given saline (n = 4–5/
time point), or 0.1, 0.3, or 1.0 mg/kg nicotine (n = 7–9/group/time point) immediately or 4-
hr prior to only the first relapse session. Upper Panel: There were no significant differences 
in water responding when the rats were administered saline or 0.1, 0.3, or 1.0 mg/kg nicotine 
immediately prior to the first relapse. Lower Panel: asterisk (*) indicates that rats 
administered saline or 0.1 mg/kg of nicotine 4-hr prior to the first relapse session responded 
significantly (p < 0.05) more on the water lever compared to baseline levels. There were no 
significant differences water responding when rats were administered 0.3 or 1.0 mg/kg 
nicotine 4-hr prior to the first relapse test.
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